Evidence map›Paper›PMID 8253949›Full record

GuidelineJournal of clinical microbiology1993

Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

S Hammer, C Crumpacker, R D'Aquila, B Jackson, J Lathey, D Livnat, P Reichelderfer

Abstract readGuidelineReview
In one paragraph

Guideline in Journal of clinical microbiology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Detection of vertical transmission of human immunodeficiency virus type 1 by a commercial polymerase chain reaction assay.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1996
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S HammerNew England Deaconess Hospital, Cambridge, Massachusetts.
C Crumpacker
R D'Aquila
B Jackson
J Lathey
D Livnat
P Reichelderfer

Funding

WOMEN'S HEALTH AGENDAU01AI025879 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL · 1987 to 2006
$14.0M
WOMEN'S HEALTH AGENDAU01AI027670 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 1988 to 2006
$13.7M
WOMEN'S HEALTH AGENDAU01AI027659 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KURITZKES, DANIEL R · 1988 to 2006
$11.8M
NIAID NIH HHS NIAID UOI-AI25879NIAID NIH HHS NIAID UOI-AI27659NIAID NIH HHS NIAID UOI-AI27670
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Polymerase Chain ReactionAcquired Immunodeficiency SyndromeClinical Trials as TopicDrug ResistanceHIV-1HIV Core Protein p24HumansMicrobial Sensitivity TestsHIV Core Protein p24

Identifiers

PMID8253949
PMCPMC265936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.